UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 476

Sortiert nach

Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial

JAMA : the journal of the American Medical Association, 1999-11, Vol.282 (20), p.1921

1999

Link zum Volltext

Verfügbarkeit prüfen

Effects of Celecoxib, a Novel Cyclooxygenase-2 Inhibitor, on Platelet Function in Healthy Adults: A Randomized, Controlled Trial

Journal of clinical pharmacology, 2000-02, Vol.40 (2), p.124-132

2000

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Osteoarthritis With Celecoxib, a Cyclooxygenase-2 Inhibitor: A Randomized Controlled Trial

Mayo Clinic proceedings, 1999-11, Vol.74 (11), p.1095-1105

1999

Link zum Volltext

Verfügbarkeit prüfen

Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitor

The American journal of gastroenterology, 2000-07, Vol.95 (7), p.1681-1690

2000

Link zum Volltext

Verfügbarkeit prüfen

Celecoxib versus diclofenac in long-term management of rheumatoid arthritis : randomised double-blind comparison

The Lancet (British edition), 1999-12, Vol.354 (9196), p.2106-2111

1999

Link zum Volltext

Verfügbarkeit prüfen

Celecoxib versus diclofenac in the management of osteoarthritis of the knee: A placebo-controlled, randomised, double-blind comparison

Scandinavian journal of rheumatology, 2001, Vol.30 (1), p.11-18

2001

Link zum Volltext

Verfügbarkeit prüfen

Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritis

The American journal of gastroenterology, 2001-04, Vol.96 (4), p.1019-1027

2001

Link zum Volltext

Verfügbarkeit prüfen

Upper gastrointestinal tolerability of celecoxib, a COX-2 specific inhibitor, compared to naproxen and placebo

Journal of rheumatology, 2000-08, Vol.27 (8), p.1876

2000

Link zum Volltext

Verfügbarkeit prüfen

Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial

Annals of internal medicine, 1995-08, Vol.123 (4), p.241

1995

Link zum Volltext

Verfügbarkeit prüfen

Renal safety and tolerability of celecoxib, a novel cyclooxygenase-2 inhibitor

American journal of therapeutics, 2000-05, Vol.7 (3), p.159-174

2000

Link zum Volltext

Verfügbarkeit prüfen

Comparative Efficacy and Safety of Celecoxib and Naproxen in the Treatment of Osteoarthritis of the Hip

Journal of international medical research, 2001-12, Vol.29 (6), p.467-479

2001

Link zum Volltext

Verfügbarkeit prüfen

Upper gastrointestinal tolerability of celecoxib compared with diclofenac in the treatment of osteoarthritis and rheumatoid arthritis

Clinical and experimental rheumatology, 2002-01, Vol.20 (1), p.35

2002

Link zum Volltext

Verfügbarkeit prüfen

Dyspepsia tolerability from the patients' perspective: a comparison of celecoxib with diclofenac

Alimentary pharmacology & therapeutics, 2002-04, Vol.16 (4), p.819-827

2002

Link zum Volltext

Verfügbarkeit prüfen

An endoscopic study of gastroduodenal lesions induced by nonsteroidal anti-inflammatory drugs

Clinical therapeutics, 1999-06, Vol.21 (6), p.992-1003

1999

Link zum Volltext

Verfügbarkeit prüfen

Celecoxib, a specific COX-2 inhibitor, has no significant effect on methotrexate pharmacokinetics in patients with rheumatoid arthritis

Journal of rheumatology, 1999-12, Vol.26 (12), p.2539

1999

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of mucosal lesions in the stomach and duodenum due to chronic use of NSAID in patients with rheumatoid arthritis or osteoarthritis, and interim report on prevention by misoprostol of diclofenac associated lesions

Journal of rheumatology. Supplement, 1991-03, Vol.28, p.11

1991

Link zum Volltext

Verfügbarkeit prüfen

Misoprostol coadministered with diclofenac for prevention of gastroduodenal ulcers : a one-year study

Digestive diseases and sciences, 1995-05, Vol.40 (5), p.1125-1131

1995

Link zum Volltext

Verfügbarkeit prüfen

Double-blind comparison of efficacy and gastroduodenal safety of diclofenac/misoprostol, piroxicam, and naproxen in the treatment of osteoarthritis

Annals of the rheumatic diseases, 1993-12, Vol.52 (12), p.881-885

1993

Link zum Volltext

Verfügbarkeit prüfen

Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: what can we expect?

Journal of rheumatology. Supplement, 1999-04, Vol.56, p.31

Geis, G S

1999

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and tolerability of celecoxib versus hydrocodone/acetaminophen in the treatment of pain after ambulatory orthopedic surgery in adults

Clinical therapeutics, 2001-02, Vol.23 (2), p.228-241

2001

Link zum Volltext

Verfügbarkeit prüfen

Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: What can we expect?

Scandinavian journal of rheumatology, 1999, Vol.28 (109), p.31-37

Geis, G. S.

1999

Link zum Volltext

Verfügbarkeit prüfen

Effects of celecoxib and naproxen on renal function in the elderly

Archives of internal medicine (1960), 2000-05, Vol.160 (10), p.1465

2000

Link zum Volltext

Verfügbarkeit prüfen

Celecoxib Does Not Significantly Alter the Pharmacokinetics or Hypoprothrombinemic Effect of Warfarin in Healthy Subjects

Journal of clinical pharmacology, 2000-06, Vol.40 (6), p.655-663

2000

Link zum Volltext

Verfügbarkeit prüfen

Comparison of once-daily and twice-daily administration of celecoxib for the treatment of osteoarthritis of the knee

Clinical therapeutics, 2001-02, Vol.23 (2), p.213-227

2001

Link zum Volltext

Verfügbarkeit prüfen

Stress ulcers and organ failure in intubated patients in surgical intensive care units

Annals of surgery, 1992-04, Vol.215 (4), p.332-337

1992

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 476

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(381)
Mit Volltextzugriff
(376)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial

Effects of Celecoxib, a Novel Cyclooxygenase-2 Inhibitor, on Platelet Function in Healthy Adults: A Randomized, Controlled Trial

Treatment of Osteoarthritis With Celecoxib, a Cyclooxygenase-2 Inhibitor: A Randomized Controlled Trial

Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitor

Celecoxib versus diclofenac in long-term management of rheumatoid arthritis : randomised double-blind comparison

Celecoxib versus diclofenac in the management of osteoarthritis of the knee: A placebo-controlled, randomised, double-blind comparison

Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritis

Upper gastrointestinal tolerability of celecoxib, a COX-2 specific inhibitor, compared to naproxen and placebo

Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial

Renal safety and tolerability of celecoxib, a novel cyclooxygenase-2 inhibitor

Comparative Efficacy and Safety of Celecoxib and Naproxen in the Treatment of Osteoarthritis of the Hip

Upper gastrointestinal tolerability of celecoxib compared with diclofenac in the treatment of osteoarthritis and rheumatoid arthritis

Dyspepsia tolerability from the patients' perspective: a comparison of celecoxib with diclofenac

An endoscopic study of gastroduodenal lesions induced by nonsteroidal anti-inflammatory drugs

Celecoxib, a specific COX-2 inhibitor, has no significant effect on methotrexate pharmacokinetics in patients with rheumatoid arthritis

Prevalence of mucosal lesions in the stomach and duodenum due to chronic use of NSAID in patients with rheumatoid arthritis or osteoarthritis, and interim report on prevention by misoprostol of diclofenac associated lesions

Misoprostol coadministered with diclofenac for prevention of gastroduodenal ulcers : a one-year study

Double-blind comparison of efficacy and gastroduodenal safety of diclofenac/misoprostol, piroxicam, and naproxen in the treatment of osteoarthritis

Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: what can we expect?

Efficacy and tolerability of celecoxib versus hydrocodone/acetaminophen in the treatment of pain after ambulatory orthopedic surgery in adults

Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: What can we expect?

Effects of celecoxib and naproxen on renal function in the elderly

Celecoxib Does Not Significantly Alter the Pharmacokinetics or Hypoprothrombinemic Effect of Warfarin in Healthy Subjects

Comparison of once-daily and twice-daily administration of celecoxib for the treatment of osteoarthritis of the knee

Stress ulcers and organ failure in intubated patients in surgical intensive care units

Suchergebnisse filtern